Prevalence of aspirin resistance in patients with type 2 diabetes.
作者： S. Fateh-Moghadam , U. Plöckinger , N. Cabeza , P. Htun , T. Reuter
DOI: 10.1007/S00592-005-0186-Y
关键词:
摘要: … (defined as systolic blood pressure ≥140 mmHg and diastolic blood pressure ≥90 mmHg and/or antihypertensive treatment), hypercholesterolaemia (blood cholesterol levels ≥200 …
springer.com
sci-hub.se 参考文章(23)
David M. Nathan, Long-term complications of diabetes mellitus The New England Journal of Medicine. ,vol. 328, pp. 1676- 1685 ,(1993) , 10.1056/NEJM199306103282306
N Vila, A Saiz, A Chamorro, R Blanc, C Ascaso, Factors associated to aspirin failure for secondary stroke prevention Medicina Clinica. ,vol. 109, pp. 569- 572 ,(1997)
M R Buchanan, S J Brister, Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Canadian Journal of Cardiology. ,vol. 11, pp. 221- 227 ,(1995)
K.-H. Grotemeyer, Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients. Thrombosis Research. ,vol. 63, pp. 587- 593 ,(1991) , 10.1016/0049-3848(91)90085-B
D. TSCHOEPE, P. ROESEN, L. KAUFMANN, S. SCHAUSEIL, B. KEHREL, H. OSTERMANN, F. A. GRIES, Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. European Journal of Clinical Investigation. ,vol. 20, pp. 166- 170 ,(1990) , 10.1111/J.1365-2362.1990.TB02264.X
M. Donatelli, E. Hoffmann, I. Colletti, G. Andolina, V. Russo, M. L. Bucalo, T. M. L. Valenti, V. Compagno, M. G. Cataldo, M. L. Morici, Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease Acta Diabetologica. ,vol. 33, pp. 246- 248 ,(1996) , 10.1007/BF02048552
Stephen B. Williams, Allison B. Goldfine, Farris K. Timimi, Henry H. Ting, Mary-Anne Roddy, Donald C. Simonson, Mark A. Creager, Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo Circulation. ,vol. 97, pp. 1695- 1701 ,(1998) , 10.1161/01.CIR.97.17.1695
J. A. Colwell, R. W. Nesto, The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. ,vol. 26, pp. 2181- 2188 ,(2003) , 10.2337/DIACARE.26.7.2181
Neil B. Ruderman, Christian Haudenschild, Diabetes as an atherogenic factor Progress in Cardiovascular Diseases. ,vol. 26, pp. 373- 412 ,(1984) , 10.1016/0033-0620(84)90011-2
Michele Sacco, Fabio Pellegrini, Maria C Roncaglioni, Fausto Avanzini, Gianni Tognoni, Antonio Nicolucci, PPP Collaborative Group, None, Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients Results of the Primary Prevention Project (PPP) trial Diabetes Care. ,vol. 26, pp. 3264- 3272 ,(2003) , 10.2337/DIACARE.26.12.3264